N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide

C9H13N3O2 — CID 75367219

IUPACN-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide
SMILESCC(=O)NC[C@H]1Cn2ccnc2CO1
InChIInChI=1S/C9H13N3O2/c1-7(13)11-4-8-5-12-3-2-10-9(12)6-14-8/h2-3,8H,4-6H2,1H3,(H,11,13)/t8-/m0/s1
InChIKeyOMQFOSSLFBKSMV-QMMMGPOBSA-N
MW195.22 g/mol
LogP-0.08
Rot. Bonds2

About N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide

N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide (PubChem CID 75367219) has the molecular formula C9H13N3O2 and a molecular weight of 195.22 g/mol. Its IUPAC name is N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide.

Molecular Properties

Compound NameN-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide
PubChem CID75367219
Molecular FormulaC9H13N3O2
Molecular Weight195.22 g/mol
Exact Mass195.10
IUPAC NameN-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide
SMILESCC(=O)NC[C@H]1Cn2ccnc2CO1
InChIInChI=1S/C9H13N3O2/c1-7(13)11-4-8-5-12-3-2-10-9(12)6-14-8/h2-3,8H,4-6H2,1H3,(H,11,13)/t8-/m0/s1
InChIKeyOMQFOSSLFBKSMV-QMMMGPOBSA-N
XLogP-0.08
TPSA56.15 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms14
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500195.22
LogP ≤ 5-0.08
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-ethyl-N-[[1-(2-methylpropyl)imidazol-2-yl]methyl]morpholine-4-carboxamide
CID 71868069
N-(2-imidazol-1-ylethyl)-3-methylmorpholine-4-carboxamide
CID 71894039
N-(2-imidazol-1-ylethyl)-2-methylmorpholine-4-carboxamide
CID 71894042
N-(3-imidazol-1-ylpropyl)-3-methylmorpholine-4-carboxamide
CID 71894161
1-cyclohexyl-3-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]urea
CID 75367241
N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]-2,2-dimethylpropan-1-amine
CID 75367326
(1-methylimidazol-2-yl)methyl (2S,6R)-2,6-dimethylmorpholine-4-carboxylate
CID 172436919
(4aR,7aS)-6-(1H-imidazol-2-ylmethyl)-4-methyl-4a,5,7,7a-tetrahydropyrrolo[3,4-b][1,4]oxazin-3-one
CID 56775105
Acetamide, N-(3-imidazol-1-ylpropyl)-2-methoxy-
CID 3148030
(4aR,7aS)-6-(1H-imidazol-2-ylmethyl)-4-propan-2-yl-4a,5,7,7a-tetrahydropyrrolo[3,4-b][1,4]oxazin-3-one
CID 56775067
N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]cyclopentanecarboxamide
CID 75367222
N-[[(6R)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]methanesulfonamide
CID 75367247

Frequently Asked Questions

What is the IUPAC name of N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide?
The IUPAC name of N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide (CID 75367219) is N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide.
What is the SMILES notation for N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide?
The canonical SMILES for N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide is CC(=O)NC[C@H]1Cn2ccnc2CO1.
What is the InChIKey of N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide?
The InChIKey is OMQFOSSLFBKSMV-QMMMGPOBSA-N. The full InChI is InChI=1S/C9H13N3O2/c1-7(13)11-4-8-5-12-3-2-10-9(12)6-14-8/h2-3,8H,4-6H2,1H3,(H,11,13)/t8-/m0/s1.
What are the key properties of N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide?
N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide has a molecular weight of 195.22 g/mol, XLogP of -0.08, 2 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[(6S)-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-6-yl]methyl]acetamide is sourced from PubChem (CID 75367219), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).